Cebix
Latest round
- Series B
Last raised
- Jan 2014
Total raised
- $66M
Investors
- 4
About Cebix
Cebix Inc. is a bio-pharmaceutical company which engages in the development of chronic replacement therapy based on human pro-insulin C-peptide for the treatment of type 1 diabetic neuropathy.
Who invested in Cebix
4 investors across 5 rounds
See all investors in Cebix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cebix
Who invested in Cebix?
Cebix has 4 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cebix raised?
Cebix has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Cebix last raise money?
Cebix's most recent round on record is a Series B, in Jan 2014.
What does Cebix do?
Cebix is a biotechnology company.
Where is Cebix headquartered?
Cebix is headquartered in US.
Which VCs invest in companies like Cebix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cebix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cebix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.